Elan Corporation
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Elan Corporation's yearly results (2022–2025), compared with Healthcare companies in Japan. Tap ? on any ratio for what it means.
What stands out
- Debt Due Cover Ratio: Debt due within a year is covered 9.3 times by its yearly operating cash. Higher than 89% of Healthcare companies in Japan.
- Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 4.7 times. Higher than 88% of Healthcare companies in Japan.
- Cash Locked Ratio: Money owed to suppliers is larger than money owed by customers plus stock: ¥1 per ¥100 of sales comes from others' credit, against ¥4 from others' credit three years earlier. Less money tied up than 85% of Healthcare companies in Japan.
Where ¥100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
¥139Over the last 3 years, every ¥100 of reported profit came with ¥139 of operating cash.
Higher than 56% of Healthcare companies in Japan.
Self-Funding Ratio
4.7×Over the last 3 years its own operating cash covered its investment spending (capex) 4.7 times.
Higher than 88% of Healthcare companies in Japan.
Cash Locked Ratio
−¥1Money owed to suppliers is larger than money owed by customers plus stock: ¥1 per ¥100 of sales comes from others' credit, against ¥4 from others' credit three years earlier.
Less money tied up than 85% of Healthcare companies in Japan.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 71% of Healthcare companies in Japan.
Growth Efficiency Ratio
¥4Sales grew 53% in 3 years; of every extra ¥100 of sales, ¥4 became extra profit.
Lower than 55% of Healthcare companies in Japan.
Asset Productivity Ratio
+53% / +64%In 3 years sales changed by +53% while total assets changed by +64%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
9.3×Debt due within a year is covered 9.3 times by its yearly operating cash.
Higher than 89% of Healthcare companies in Japan.
Cash Cushion Ratio
+14%Cash, after subtracting all debt, equals 14% of its market value (net cash).
Higher than 68% of Healthcare companies in Japan.
Tangible Assets Ratio
93%Of every ¥100 the company owns, ¥93 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 65% of Healthcare companies in Japan.
Tangible Net Worth Ratio
87%Of every ¥100 of net worth, ¥87 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 62% of Healthcare companies in Japan.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Elan Corporation owes ¥0.42 for every ¥1 it owns. Net profit rose 18% in the year to Dec 2025, and grew 10% a year on average over 3 years.
Compared with Healthcare companies in Japan · latest annual results Dec 2025.
P/E ratio
13.7Investors pay ¥13.7 for every ¥1 of Elan Corporation's yearly profit, lower than 59% of Healthcare companies in Japan.
P/B ratio
2.97The share price is 2.97 times Elan Corporation's book value per share, higher than 79% of Healthcare companies in Japan.
Market cap
¥43.1 BThe total market value of all of Elan Corporation's shares at today's price (share price × number of shares), larger than 64% of Healthcare companies in Japan. PosiCap size class: Mini Cap.
Net worth (book value)
¥14.5 BWhat Elan Corporation would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
¥240.04Net worth divided by the number of shares. The share price of ¥712.00 is 3.0 times this, which is the P/B above.
Return on equity (ROE)
22.0%Elan Corporation earned 22.0% on its shareholders' money over the last year, higher than 92% of Healthcare companies in Japan.
Owes vs Owns
0.42×Elan Corporation owes ¥0.42 for every ¥1 it owns (low), higher than 53% of Healthcare companies in Japan.
Dividend yield
2.19%Elan Corporation pays 2.19% of its share price as dividends a year, lower than 64% of dividend-paying Healthcare companies in Japan.
Revenue growth
+17%Revenue rose 17% in the year to Dec 2025, and grew 15% a year on average over 3 years.
Profit growth
+18%Net profit rose 18% in the year to Dec 2025, and grew 10% a year on average over 3 years.
Profit margin
5.0%Elan Corporation keeps ¥5 of every ¥100 of revenue as net profit.
Cash quality
1.6×Cash from Elan Corporation's business was 1.6× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
72.4×Elan Corporation's operating profit covered its interest costs 72.4 times in the year to Dec 2025.
Cash vs debt
Net cashElan Corporation held ¥6.0 B more cash than debt (net cash) at Dec 2025.
Questions
What is Elan Corporation's P/E ratio?
Investors pay ¥13.7 for every ¥1 of Elan Corporation's yearly profit, lower than 59% of Healthcare companies in Japan.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Elan Corporation: ¥43.1 B ÷ ¥14.5 B (31 Mar 2026) = 3.0.
What is Elan Corporation's return on equity?
Elan Corporation earned 22.0% on its shareholders' money over the last year, higher than 92% of Healthcare companies in Japan.
How much does Elan Corporation owe compared with what it owns?
Elan Corporation owes ¥0.42 for every ¥1 it owns (low), higher than 53% of Healthcare companies in Japan.
Does Elan Corporation pay a dividend?
Yes. Elan Corporation pays 2.19% of its share price as dividends a year, lower than 64% of dividend-paying Healthcare companies in Japan.
Is Elan Corporation's revenue growing?
Revenue rose 17% in the year to Dec 2025, and grew 15% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.